Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Exagen (XGN) over the last 5 years, with Q3 2025 value amounting to $1.8 million.

  • Exagen's Treasury Shares fell 251.63% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 251.63%. This contributed to the annual value of $1.7 million for FY2024, which is 2327.38% up from last year.
  • Exagen's Treasury Shares amounted to $1.8 million in Q3 2025, which was down 251.63% from $1.7 million recorded in Q2 2025.
  • Exagen's 5-year Treasury Shares high stood at $1.8 million for Q1 2025, and its period low was $185000.0 during Q1 2021.
  • Over the past 5 years, Exagen's median Treasury Shares value was $1.5 million (recorded in 2023), while the average stood at $1.2 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 37490.54% in 2022, then crashed by 251.63% in 2025.
  • Exagen's Treasury Shares (Quarter) stood at $415325.0 in 2021, then skyrocketed by 149.49% to $1.0 million in 2022, then skyrocketed by 33.9% to $1.4 million in 2023, then rose by 23.27% to $1.7 million in 2024, then increased by 3.19% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $1.7 million for Q2 2025, and $1.8 million during Q1 2025.